Johnson & Johnson unit enters $310 million antibiotic deal
Basilea Pharmaceutica of Switzerland has entered into an exclusive worldwide agreement with Johnson & Johnson subsidiary Cilag International for the ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.